Abstract
OBJECTIVE--To investigate whether angiotensin converting enzyme inhibitors reduce diuretic induced magnesium excretion in patients in congestive cardiac failure. DESIGN--Cohort analytic study. SETTING--A London district general hospital. SUBJECTS--Thirty four patients with chronic congestive cardiac failure caused by ischaemic heart disease or cardiomyopathy selected consecutively from inpatients under the care of two consultant cardiologists. Nineteen patients (group 1) on diuretics alone were compared with 15 patients (group 2) taking diuretics plus either enalapril or captopril. All drug regimens were stable for at least three months before the study. Patients with impaired renal function (plasma creatinine greater than 120 mumol/l) were excluded. INTERVENTIONS--An intravenous loading dose of magnesium sulphate was given to minimise the variability in baseline magnesium state. MAIN OUTCOME MEASURE--Total urine magnesium excretion and creatinine clearance in 24 hour urine collections. RESULTS--Plasma magnesium was similar in the two groups. However, 24 hour urine magnesium excretion was significantly lower in group 2 than in group 1. Furthermore, creatinine clearance was also significantly lower in group 2 and correlated strongly with magnesium excretion. There was no such relation in group 1. There was no difference in fractional clearance of magnesium between groups. CONCLUSION--Angiotensin converting enzyme inhibitors have an important magnesium conserving action, possibly via their effect on glomerular filtration rate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dirks J. H. The kidney and magnesium regulation. Kidney Int. 1983 May;23(5):771–777. doi: 10.1038/ki.1983.93. [DOI] [PubMed] [Google Scholar]
- Dyckner T., Wester P. O. Magnesium deficiency - guidelines for diagnosis and substitution therapy. Acta Med Scand Suppl. 1982;661:37–41. doi: 10.1111/j.0954-6820.1982.tb00391.x. [DOI] [PubMed] [Google Scholar]
- Dørup I., Skajaa K., Clausen T., Kjeldsen K. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. Br Med J (Clin Res Ed) 1988 Feb 13;296(6620):455–458. doi: 10.1136/bmj.296.6620.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gottlieb S. S., Baruch L., Kukin M. L., Bernstein J. L., Fisher M. L., Packer M. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol. 1990 Oct;16(4):827–831. doi: 10.1016/s0735-1097(10)80329-8. [DOI] [PubMed] [Google Scholar]
- Hollifield J. W. Magnesium depletion, diuretics, and arrhythmias. Am J Med. 1987 Mar 20;82(3A):30–37. doi: 10.1016/0002-9343(87)90130-6. [DOI] [PubMed] [Google Scholar]
- Packer M., Lee W. H., Kessler P. D. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation. 1986 Oct;74(4):766–774. doi: 10.1161/01.cir.74.4.766. [DOI] [PubMed] [Google Scholar]
- Rasmussen H. S., McNair P., Gøransson L., Balsløv S., Larsen O. G., Aurup P. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med. 1988 Feb;148(2):329–332. [PubMed] [Google Scholar]
- Whang R. Magnesium deficiency: pathogenesis, prevalence, and clinical implications. Am J Med. 1987 Mar 20;82(3A):24–29. doi: 10.1016/0002-9343(87)90129-x. [DOI] [PubMed] [Google Scholar]